ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

May 10, 2002

Susan Sieber, Former NCI Communications Chief, Dead.

January 25, 2002

Formal Guidelines For Training Grants Developed By NCI

December 7, 1979

Translplants Not Best Choice in Subset of ALL Patients

April 27, 2012

NAS To Honor Outstanding Scientists

February 28, 1997

H. Lee Moffitt Cancer Designated A Comprehensive Cancer Center By NCI.

May 4, 2001